You are here:

Home
NICE Guidance
Conditions and diseases
Cancer
Breast cancer

Breast cancer Products

A list of all our products on breast cancer

Filter

Product type

Product typeGuidanceQuality standardsAdvice

Guidance programme

Guidance programmeNICE guidelinesTechnology appraisal guidanceHealthTech guidanceInterventional procedures guidanceMedical technologies guidance

Status
1 selected

StatusPublishedIn consultationIn developmentAwaiting developmentTopic prioritisation

New and updated

New and updatedNew in the last 6 monthsUpdated in the last 6 months

Showing 1 product

Sort by: Date | Sort by Title

Status: In consultationRemove ‘Status: In consultation’ filter

Inavolisib with palbociclib and fulvestrant for treating recurrent hormone receptor-positive HER2-negative PIK3CA-positive advanced breast cancer after adjuvant endocrine treatment [ID6425]
Status:
In development | In consultation
Programme:
Technology appraisal guidance
Consultation end date:
18 June 2026
Expected publication date:
30 September 2026